Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
2.150
-0.200 (-8.51%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sintx Technologies Revenue
In the year 2025, Sintx Technologies had annual revenue of $1.02M, down -64.74%. Sintx Technologies had revenue of $290.00K in the quarter ending December 31, 2025, a decrease of -46.49%.
Revenue (ttm)
$1.02M
Revenue Growth
-64.74%
P/S Ratio
8.71
Revenue / Employee
$31,813
Employees
32
Market Cap
8.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.02M | -1.87M | -64.74% |
| Dec 31, 2024 | 2.89M | 260.00K | 9.90% |
| Dec 31, 2023 | 2.63M | 1.07M | 68.29% |
| Dec 31, 2022 | 1.56M | 955.00K | 157.59% |
| Dec 31, 2021 | 606.00K | 12.00K | 2.02% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 48.57M |
| Vivos Therapeutics | 17.44M |
| Beyond Air | 6.92M |
| Biomerica | 4.33M |
| Tenon Medical | 3.94M |
| Intelligent Bio Solutions | 3.58M |
| Co-Diagnostics | 622.49K |
| iTonic Holdings | 523.03K |
SINT News
- 5 weeks ago - SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution - GlobeNewsWire
- 5 weeks ago - SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - GlobeNewsWire
- 2 months ago - SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms - GlobeNewsWire
- 3 months ago - SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5 - GlobeNewsWire
- 5 months ago - SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants - GlobeNewsWire
- 6 months ago - SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System - GlobeNewsWire
- 6 months ago - SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System - GlobeNewsWire
- 7 months ago - SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics - GlobeNewsWire